FOLH1 and prostate carcinoma: In mice bearingDU145 PSMA-positive and PSMA-negative prostate cancer xenografts,the uptake of [201Tl]Tl-pypa-PSMA in DU145 PSMA-positivetumors was higher than that in DU145 PSMA-negative tumors but insufficientfor useful tumor targeting.